Archives
|
Entry
|
Blogger
|
Date
▴
|
Location
|
|
Hepatitis C Drug From Anadys Shows Quick Virus-Killing Punch
|
Luke Timmerman |
01/08/09 |
San Diego
|
|
San Diego’s Forward Ventures Moves Toward a Lean and Virtual Future
|
Bruce V. Bigelow |
01/07/09 |
San Diego
|
|
Broad Institute Scientists’ Forma Therapeutics Raises $25M, Aims to Knock Out Underpinnings of Cancer
|
Ryan McBride |
01/06/09 |
Boston
|
|
Can’t Take My Eyes Off Of You: The Untold Story of How a San Diego VC Backed Broadway’s Jersey Boys
|
Bruce V. Bigelow |
12/31/08 |
San Diego
|
|
Biotech Veteran Talks of Hedge Fund Investing, Boston Celtics, and Hot Companies
|
Ryan McBride |
12/18/08 |
Boston
|
|
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/17/08 |
Boston
|
|
Economy Makes Disease Foundations Get Choosier
|
Ryan McBride |
12/15/08 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News
|
Rebecca Zacks |
11/05/08 |
Boston
|
|
Vertex Co-Founder’s Hedge Fund RA Capital Makes Waves in Biotech Industry with Former Harvard Grad Student at Helm
|
Ryan McBride |
11/03/08 |
Boston
|
|
Vertex Drug for Hepatitis C Shows Durable Virus-Killing Ability in Tough-to-Treat Patients
|
Luke Timmerman |
11/01/08 |
Boston
|
|
Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds
|
Luke Timmerman |
11/01/08 |
San Diego
|
|
Vertex Gears up for Big Liver Disease Conference
|
Luke Timmerman |
10/29/08 |
Boston
|
|
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/22/08 |
Boston
|
|
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days
|
Luke Timmerman |
10/20/08 |
Boston
|
|
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV
|
Luke Timmerman |
10/14/08 |
Boston
|
|
ZymoGenetics “Sleeper” for Hepatitis C Aims to Wipe Out Side Effects of Anti-Viral Therapy
|
Luke Timmerman |
09/30/08 |
Seattle
|
|
Sirtris Settles in at GSK, Alnylam Raises IP Questions on Bio Bill, Targanta Takes on Cubist’s Market, & More Life Sciences News
|
Rebecca Zacks |
09/24/08 |
Boston
|
|
Vertex Offering Up To $220M
|
Rebecca Zacks |
09/22/08 |
Boston
|
|
Vertex Prices Stock Offering, $7M for Rapid7, Global Insight and NextPoint Acquired, & More Boston-Area Deals News
|
Rebecca Zacks |
09/22/08 |
Boston
|
|
Cocrystal Discovery Raises $10 Million To Make Pills Against Viral Infections
|
Luke Timmerman |
09/19/08 |
Seattle
|
|
Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News
|
Rebecca Zacks |
09/10/08 |
Boston
|
|
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News
|
Rebecca Zacks |
08/20/08 |
Boston
|
|
Vertex Drug Poised for Pivotal Trial Among Patients Who Fail Prior Hepatitis C Treatments
|
Luke Timmerman |
08/19/08 |
Boston
|
|
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News
|
Rebecca Zacks |
08/06/08 |
Boston
|
|
Vertex Marching Ahead With Cystic Fibrosis Program
|
Luke Timmerman |
08/01/08 |
Boston
|
|
Caliper Bets Future on Tools That Light Up Genes Before Researchers’ Eyes
|
Luke Timmerman |
07/28/08 |
Boston
|
|
Massachusetts Life Sciences Center Announces Board, Approves $7 Million in Grants
|
Luke Timmerman |
07/23/08 |
Boston
|
|
Infinity Adds Two New Members To Board of Directors
|
Luke Timmerman |
07/22/08 |
Boston
|
|
Vertex Moves Hepatitis Drug Forward, Merrimack Rakes in $60M, Biogen and Icahn Trade Barbs, & More Life Sciences News
|
Rebecca Zacks |
06/12/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
